C 27 H 18 FN 3 O 3 S, monoclinic, P21/c (no. 14), a = 8.091 (6) 
Bruker programs [1] , SHELX [2, 3] for about 36 h, the mixture was added into 100 mL acetone. The precipitate was filtered and subsequently washed by acetone to provide a yellow intermediate. Then, the yellow intermediate and 4-fluorophenylsulfonylfluoride (0.89 g, 5.0 mol) were dissolved in 50 mL of dichloromethane. Potassium carbonate (2.76 g, 0.02 mol) was added and the mixture was stirred for 12 h at room temperature. The precipitate was collected, washed with water and recrystallized from dichloromethane/methanol (2:1, v/v) to get light yellow crystals of the title compound.
Experimental details
All H atoms were placed in idealized positions and treated as riding on their parent atoms, with
Discussion

Curcumin
(1,7-bis(4-hydroxy-3-methoxyphenyl)1,6-heptadien-3,5-dion) is a yellow pigment extracted from the rhizome of turmeric, which has anti-inflammatory, anti-tumor, antioxidation and other activities. However, the clinical application of curcumin is limited due to its low anticancer activity and poor bioavailability [4] . In order to improve these defects, a new class of curcumin analogs (3E,5E)-3,5-bis(arylidene)-4-piperidones (BAP) have been reported as better antitumor agents [5] [6] [7] [8] [9] . The pharmacophore of BAP is 1,5-diaryl-3-oxo-1,4-pentadienyl, which contains two α,β-unsaturated keto groups and has a greater predilection or sequential interaction for bio-thiols resulting in a greater activity to tumors rather than with normal cells. For example, 3,5-bis(2-fluorobenzylidene)-4-piperidone (EF24) is a more potent antitumor drug than curcumin that disrupts the microtubule cytoskeleton and inhibits HIF-1 [10] . Our interests lie in incorporation of strong electronwithdrawing substituent groups on both sides of BAP. In addition, we expect that inflammatory activity [11] [12] [13] . In previous study, crystal structure and bioactivity of 4-((E)-((E)-5-(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)-4-oxopiperidin-3-ylidene)methyl)benzonitrile (BAP-1) was reported [7, 14] , which is a dissymmetric compound. In this study, we report herein the crystal structure of (3E,5E)-3,5-bis (4-cyanobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one.
There is one molecule in the asymmetric unit of the title crystal structure (cf. the figure). Bond lengths and angles are all in the expected ranges. Single-crystal structure analysis reveals that two 4-cyano phenyl groups on both sides of 3,5-bis(arylidene)-4-piperidone are symmetric compared with central piperidin-4-one. The piperidin-4-one moiety shows the typical folding. The E stereochemistry of olefinic double bonds is adopted [15] . And the dihedral angles between two 4-cyano phenyl groups is 37°. The 2-fluorophenyl group is almost coplanar with 1,5-diaryl-3-oxo-1,4-pentadienyl moiety, which can be proved by the dihedral angles (16.36(4)°). On the whole, the title molecule looks like an "organic clip" [16] . The heteroatoms (F, N, O, S) can act as hydrogen bonding acceptors for biological macromolecules with the aim of creating more potent cytostatica [17] .
